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Adriamycin (ADM) in a low weekly dose (1hg/~2) was used as a single agent for maintenance of remission (RMS) in 24 previously treated children with acute lymphoblastic leukemia (ALL). The dose was escalated by 2mg/~2 weekly until WBC count remained between 3,000-3.500/mm3. The thera y was discontinued when cummula-P From 1971 to 1974 children with previously untreated ALL were entered on protocol 7111. Ninety-six of the 646 evaluable patients developed CNS leukemia: 6 during their initial therapy 18 prior to receiving "prophylactic" treatment to the CNS and 72 subsequent to such therapy but before (64) or simultaneously with (8) a bone marrow relapse.
Twenty-two (23%) of these patients are still in their initial marrow remission for a median duration of 53 months (24-73 months). Only 4 of these 22 had initial white counts over 30,000 and none of them were under 2 years of age at the time o diagnosis. Of the 74 who have had marrow relapses concomitant with or following a CNS relapses 27 had initial white counts over 30,000 and 11 of them were under 2 years of age at diagnosis.
The survival subsequent to the first relapse when the first relapse occurs in the CNS was superior (median 15.5 months) to that seen with initial marrow relapse (7.3 months) or simultaneous marrow and CNS relapse (4.2 months).
While it is certainly preferable that children with ALL do not relapse, these data suggests that our present ability effectively to treat overt CNS leukemia exceeds our ability to maintain long second hematologic remissions. ed (Prasad, A.S., et al: JAMA 235:2396, 1976 ). The present stud was carried out to investigate zinc status in children with SCD.
FACTOR XI AND XI1 IN CRITICALLY ILL NEONATES. 5
Karpatkin, (Spon. by S. P i m e l l i ) , NY Univ. Med. C t r .
I t has been r e p o r t e d t h a t f a c t o r s XI and XI I a r e low i n neonates and r i s e s l o w l y i n t h e post-natal p e r i o d , lowest l e v e l s a r e r e p o r t e d i n t h e premature. T h i s study demonstrates t h a t i n very s i c k newborns, l e v e l s o f these f a c t o r s a r e extremel y low, i r r e s p e c t as 4-47% (mean 17%) and f a c t o r XI l 9-388 (mean 20%). These lev-I s a r e lower than those p r e v i o u s l y r e p o r t e d i n newborns; a l s o i n 5 i n f a n t s o f comparable age n o t i n t h e ICU, PTT was 47-77 ecs. Mean age a t t i m e o f study was 2.8 days, range 1-8, mean i r t h weight 16289 (range 700-3250). There was no c o r r e l a t i o n 2etween b i r t h weight o r age and f a c t o r l e v e l s . I n 5 babies studied 1-4 days l a t e r , l e v e l s d e c l i n e d i n 4 and were unchanged i n I .
i v e o f g e s t a t i o n a l age and do n o t r i s e i n t h e immediate p o s t n a t a l p e r i o d . Of 25 consecutive babies i n t h e ICU w i t h severe RDS

I n v i t r o i n h i b i t i o n c o u l d n o t be demonstrated. There was no ?vidence o f DIC o r gross h e p a t i c d i s f u n c t i o n (PT mean 14.3 secs.
range 11-17, f i b r i n o g e n > 150mg%, FSP < 3.38~g/ml, f a c t o r VI I I Hematologic abnormalities have been associated with some inborn errors of metabolism, including maple syrup urine disease and methylmalonic acidemia. We have evaluated two neonates with isovaleric acidemia. Both patients had pancytopenia during the first week of life when serum isovaleric acid levels were in excess of 50 mg/dl. Hemoglobin, granulocyte and platelet counts decreased further, reaching nadirs by the 2nd week of life of 7.8 and 8.0 /dl, 26 and 150 cells/wm3, and 8.000 and 50,000 platelets/mmg, respectively, even as serum isovaleric acid levels were decreasing in response to therapy. Recovery was gradual, requiring 2 weeks for restoration of normal values. The granulocytes were the last to return to normal. A striking monocytosis (40% and 60%) was noted during the recovery phase in both infants. One infant also had an eosinophilia of 19%. Bone marrow examination in one patient revealed large numbers of immature mononuclear cells, with small numbers of early erythroid and myelbid precursors. Bone marrow culture showed an increased number of granulocytic colony forming units. Survival of random donor platelets was normal. These findings suggest that the hematologic abnormalities of isovaleric acidemia probably are referable to an inhibition of normal cell maturation rather than a depletion of marrow precursors or increased destruction of mature cells. Their Hb values (7.4 to 9.2 g/dl) and reticulocyte counts (468 to 700 x 109/1) did not differ from those of the other 25 patients. Eight of these nine children showed normal to high MCVs ranging from 77 to 100 fl; one had an MCV of 63 fl. Globin chain separation by carboxymethylcellulose chromatography follow ing the method.of Cleggs and Weatherall was performed in five of the nine high HB A2 children including the one with the low MCV, and all showed a normal a/B chain ratio ranging from 0.91 to 1.05. The fetal Hb in these five subjects ranged from 1.2 to 6.6% and was not different from the values of the other 29 HSCA patients. ~n elevated Hb A2 level may be found in a significant proportion of HSCA patients. In addition to careful analysis of the MCV, globin chain synthesis studies may be necessary to differentiate these patients from subjects with sickle-6 thalassemia.
> 70%). Thus i n very s i c k newborns f a c t o r s XI and XI1 a r e extremely low. T h i s i s u n r e l a t e d t o b i r t h weight b u t may r e l a t e t o 3oor c l i n i c a l s t a t u s . Other f a c t o r s were i n normal
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